← Back
$PCRX All transactions

Pacira BioSciences, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

1,500

Price

$0

Filed

Apr 22

Insider

Name

Cross Shawn

Title

Chief Financial Officer

CIK

0001734779

Roles

Officer

Transaction Details

Transaction Date

2026-04-22

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

162,941

Footnotes

The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.31, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive. | The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Filing Info

Accession No.

0001628280-26-026669

Form Type

4

Issuer CIK

0001396814

Cross Shawn's History

Date Ticker Type Value
2026-04-22 PCRX M $25K
2026-04-22 PCRX $38K
2026-04-22 PCRX M $0
2026-04-21 PCRX M $47K
2026-04-21 PCRX $71K
2026-04-21 PCRX M $0
2026-04-20 PCRX M $127K
2026-04-20 PCRX $194K
2026-04-20 PCRX M $0
2026-02-11 PCRX A $0

Other Insiders at PCRX (90d)

Insider Bought Sold Last
WILLIAMS KRISTEN
Chief Administrative Officer
$270K 2026-02-11
RIKER LAUREN
Senior Vice President, Finance
$83K 2026-02-11
Kronenfeld Mark A. 2025-06-11
Froimson Mark $11K 2026-03-17
Cross Shawn
Chief Financial Officer
$303K 2026-04-22
Hirawat Samit 2026-01-27
Lee Frank D.
Chief Executive Officer
2026-02-11
SLONIN JONATHAN
Chief Medical Officer
$74K 2026-03-17
Teehan Brendan
Chief Commercial Officer
2026-02-11